The most important late complication of myocardial infarction is congestive heart failure, which often results from pathologic left ventricular remodeling. Currently no therapy directly addresses repair or replacement of damaged myocardium. Cellular cardiomyoplasty, the technique of transplanting progenitor cells into the heart, represents a highly promising new treatment strategy. Among the different potential cellular sources, mesenchymal stem cells (MSCs) derived from bone marrow are emerging as a leading candidate. We have shown in a swine model of infarction that MSCs can be transplanted by intramyocardial (IM) injection (via surgical or percutaneous approaches) with robust engraftment and differentiation into a myocyte-like phenotype, resulting in improved LV function and attenuated remodeling. Yet many challenges remain before translating this treatment strategy into clinical use. Accordingly, we propose studies to further simplify MSC delivery and develop noninvasive means of assessing their engraftment and effect. Using swine chronically instrumented to measure cardiac mechanical efficiency and randomized to a particular mode of MSC delivery following infarction, we will first test two hypotheses: 1) intracoronary delivery of stem cells is equivalent or superior to IM administration, with respect to engraftment, cardiac energetics and function, and 2) there is an optimum time frame during which MSC transplantation yields maximum engraftment. Subsequently, in noninstrumented animals similarly randomized we will test the additional hypotheses that: 3) MSCs can be magnetically labeled, located and quantified by MRI following transplantation, and 4) MRI can reliably determine the impact of transplanted MSCs on cardiac function and infarct size. The results of these studies will provide novel insights into the optimum mode and timing of MSC delivery and will show that both their fate and impact on ventricular remodeling can be noninvasively assessed by MRI. Furthermore, these noninvasive techniques will be immediately transferable to human clinical trials.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21HL072185-02
Application #
6661241
Study Section
Special Emphasis Panel (ZHL1-CSR-O (S1))
Program Officer
Lundberg, Martha
Project Start
2002-09-30
Project End
2005-07-31
Budget Start
2003-08-01
Budget End
2004-07-31
Support Year
2
Fiscal Year
2003
Total Cost
$245,250
Indirect Cost
Name
Johns Hopkins University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Da Silva, Jose S; Hare, Joshua M (2013) Cell-based therapies for myocardial repair: emerging role for bone marrow-derived mesenchymal stem cells (MSCs) in the treatment of the chronically injured heart. Methods Mol Biol 1037:145-63
Schuleri, Karl H; Amado, Luciano C; Boyle, Andrew J et al. (2008) Early improvement in cardiac tissue perfusion due to mesenchymal stem cells. Am J Physiol Heart Circ Physiol 294:H2002-11
Mazhari, Ramesh; Hare, Joshua M (2007) Advances in cell-based therapy for structural heart disease. Prog Cardiovasc Dis 49:387-95
Amado, Luciano C; Schuleri, Karl H; Saliaris, Anastasios P et al. (2006) Multimodality noninvasive imaging demonstrates in vivo cardiac regeneration after mesenchymal stem cell therapy. J Am Coll Cardiol 48:2116-24
Lehrke, Stephanie; Mazhari, Ramesh; Durand, Daniel J et al. (2006) Aging impairs the beneficial effect of granulocyte colony-stimulating factor and stem cell factor on post-myocardial infarction remodeling. Circ Res 99:553-60
Madar, Igal; Ravert, Hayden T; Du, Yong et al. (2006) Characterization of uptake of the new PET imaging compound 18F-fluorobenzyl triphenyl phosphonium in dog myocardium. J Nucl Med 47:1359-66
Boyle, Andrew J; Schulman, Steven P; Hare, Joshua M et al. (2006) Is stem cell therapy ready for patients? Stem Cell Therapy for Cardiac Repair. Ready for the Next Step . Circulation 114:339-52
Amado, Luciano C; Saliaris, Anastasios P; Schuleri, Karl H et al. (2005) Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A 102:11474-9
Bhatia, Rinky; Hare, Joshua M (2005) Mesenchymal stem cells: future source for reparative medicine. Congest Heart Fail 11:87-91; quiz 92-3
Zimmet, Jeffrey M; Hare, Joshua M (2005) Emerging role for bone marrow derived mesenchymal stem cells in myocardial regenerative therapy. Basic Res Cardiol 100:471-81